|
|
|
|
Trial | Studied trt | Control trt | patients | tags | ROB | Trial result | |
---|
|
Costanza, 1999 | carboplatin followed by CAF | CAF | | | | suggesting | |
Creagan ET, 1984 | CAP | CFP | | | | suggesting | |
Cocconi, 1991 | cisplatin + etoposide | CMF | | | | suggesting | |
Cocconi, 1999 | CMF, cisplatin, etoposide, and doxorubicin | CMF | | | | suggesting | |
Cocconi G, 1996 | MPEPIV or MPEMi | CMF | | | | suggesting | |
Kolaric, 1985 | CAP | CMFVP | | | | suggesting | |
Eisen, 1998 | EcisF | ECycloF | | | | negative | |
Nielsen, 2000 | EPI + CIS | EPI | | | | suggesting | |
Kolaric, 1989 | CAP | FAC | | | | suggesting | |
Berruti A, 2002 | cisplatin + epirubicin | lonidamine + epirubicin | | | | negative | |
Berruti B, 2002 | cisplatin + epirubicin | lonidamine + epirubicin | | | | suggesting | |
Icli, 2002 | VP-16+P | paclitaxel | | | | suggesting | |
Fountzilas, 2002 | PCb | PE | | | | negative | |